634 related articles for article (PubMed ID: 10987308)
1. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM
Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
Bae SH; Jung ES; Park YM; Kim BS; Kim BK; Kim DG; Ryu WS
Clin Cancer Res; 2001 May; 7(5):1410-8. PubMed ID: 11350912
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclooxygenase 2 in human malignant melanoma.
Denkert C; Köbel M; Berger S; Siegert A; Leclere A; Trefzer U; Hauptmann S
Cancer Res; 2001 Jan; 61(1):303-8. PubMed ID: 11196178
[TBL] [Abstract][Full Text] [Related]
5. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
[TBL] [Abstract][Full Text] [Related]
7. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
[TBL] [Abstract][Full Text] [Related]
8. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ
Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
[TBL] [Abstract][Full Text] [Related]
10. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ
J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617
[TBL] [Abstract][Full Text] [Related]
12. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.
Elder DJ; Halton DE; Hague A; Paraskeva C
Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550
[TBL] [Abstract][Full Text] [Related]
14. A selective cyclooxygenase-2 inhibitor, NS-398, inhibits cell growth by cell cycle arrest in a human malignant fibrous histiocytoma cell line.
Yamashita H; Osaki M; Honjo S; Yoshida H; Teshima R; Ito H
Anticancer Res; 2003; 23(6C):4671-6. PubMed ID: 14981912
[TBL] [Abstract][Full Text] [Related]
15. [Expression of cyclooxygenase (COX)-2 in astrocytic tumors and anti-tumor effects of selective COX-2 inhibitors].
Murakami H; Sawa H; Kamada H
No To Shinkei; 2006 Jan; 58(1):43-9. PubMed ID: 16482921
[TBL] [Abstract][Full Text] [Related]
16. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Ding XZ; Tong WG; Adrian TE
Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
[TBL] [Abstract][Full Text] [Related]
17. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A
Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response.
Ferrario A; Von Tiehl K; Wong S; Luna M; Gomer CJ
Cancer Res; 2002 Jul; 62(14):3956-61. PubMed ID: 12124326
[TBL] [Abstract][Full Text] [Related]
19. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells.
Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H
J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416
[TBL] [Abstract][Full Text] [Related]
20. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
Lee DW; Sung MW; Park SW; Seong WJ; Roh JL; Park B; Heo DS; Kim KH
Anticancer Res; 2002; 22(4):2089-96. PubMed ID: 12174888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
